PKU Founder Group itself is a subsidiary of Peking University, in turn making the listed company a state-owned enterprise by broader definition.

Due to financial difficulties, 1.26% shares of the listed company was acquired by Sichuan No.2 Electric Power Construction in 2001 from the parent entity (Southwest Synthetic Pharmaceutical Factory).

[3] In June 2003, China Huarong Asset Management, the state-owned bad bank, made a public offer to sell the credit of themselves to the parent entity (Southwest Synthetic Pharmaceutical Factory).

[4] On 4 September the parent entity was re-incorporated as Chongqing Southwest Synthetic Pharmaceutical Co., Ltd. (Chinese: 重庆西南合成制药有限公司),[nb 1] with part of the debt was converted into share capital, making state-owned China Development Bank owned 39.80% share capital as second largest shareholder.

[10][11] However, it was later found that the private company did not pay PKU Healthcare Group due to its financial difficulty.